window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 1, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Research & Development

  • Facilities and infrastructure,Healthcare leadership,Research & Development

    Horiba UK launches philanthropic foundation to advance scientific research and broaden STEM participation

    Horiba UK has launched the Horiba Foundation UK, a new [...]

    November 25, 2025
  • Biotech,Immunology,Research & Development,Technology and platforms

    Macomics updates Enigmac platform data and highlights macrophage role in fibrotic disease

    Macomics has released new data supporting the use of its [...]

    November 25, 2025
  • Biologics & Biosimilars,Biotech,Clinical Development,Drug Development,Genomics and sequencing,Research & Development,Respiratory

    Flagship Pioneering signs new agreements with ProFound Therapeutics and Quotient Therapeutics with GSK collaboration

    Flagship Pioneering has announced that ProFound Therapeutics and Quotient Therapeutics [...]

    November 20, 2025
  • Artificial Intelligence,Clinical Development,Clinical Trials,Digital Health,Neurosciences,Research & Development

    Linus Health to present AI-driven brain health research at CTAD 2025

    Linus Health, an AI-driven brain health company focused on early [...]

    November 20, 2025
  • Biotech,Research & Development,Women in Pharma

    BioGrad leads £6 million PCR machine donation to strengthen UK science education

    BioGrad has led the donation of more than £6 million [...]

    November 20, 2025
  • Artificial Intelligence,Biotech,Digital Health,Research & Development,Technology and platforms

    Elsevier launches LeapSpace an AI-assisted workspace to accelerate research and discovery

    Elsevier has launched LeapSpace, a next-generation AI-assisted workspace designed to [...]

    November 20, 2025
  • Biotech,Clinical Development,Drug Development,European biotech,Movers & Shakers,Oncology,Research & Development

    Mosaic Therapeutics appoints Stephen Shuttleworth as chief scientific officer

    Mosaic Therapeutics has appointed Stephen Shuttleworth as chief scientific officer [...]

    November 20, 2025
  • Artificial Intelligence,Genomics and sequencing,Research & Development

    Sheba, Mount Sinai and NVIDIA launch AI collaboration to decode unexplored regions of the human genome

    ARC Innovation at Sheba Medical Center and the Icahn School [...]

    November 18, 2025
  • Chronic diseases,Drug Development,Genomics and sequencing,Pharmaceuticals and therapeutics,Research & Development

    Ochre Bio and GSK complete research phase with large-scale human liver genomics datasets

    Ochre Bio has completed the research phase of its collaboration [...]

    November 18, 2025
  • Oncology,Pharmaceuticals and therapeutics,Research & Development

    UK nuclear materials to power new precision cancer therapies

    The UK is launching a major programme to convert used [...]

    November 18, 2025
Previous121314Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • SonoNeu exits stealth as part of $41.3M ARPA-H programme to advance sonogenetics
    Categories: Clinical Development, Neurosciences, Partnerships & Funding, Research & Development
  • AC Immune amends Lilly collaboration on Tau small molecules for Alzheimer’s disease
    Categories: Clinical Development, Neurosciences, Partnerships & Funding, Research & Development
  • Anixa Biosciences advances breast cancer vaccine toward Phase 2 with Cytovance manufacturing deal
    Categories: Biologics & Biosimilars, Clinical Trials, Manufacturing, Oncology, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top